MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
January 13, 2025 05:00 ET
|
mdxhealth
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance IRVINE, CA – January 13, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH)...
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
January 13, 2025 03:05 ET
|
MaxCyte, Inc
ROCKVILLE, Md., Jan. 13, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025 02:08 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and...
DTEK selects Fluence to deliver 200 MW advanced energy storage systems in Ukraine
January 13, 2025 02:00 ET
|
Fluence
The €140 million total investment aims to enhance power grid stability, bolstering Ukraine’s energy security and independence.The project is split between six energy storage sites across Ukraine and...
Himax Technologies, Inc. Schedules Fourth Quarter and Full Year 2024 Financial Results Conference Call on Thursday, February 13, 2025, at 8:00 AM EST
January 13, 2025 01:56 ET
|
Himax Technologies, Inc.
TAINAN, Taiwan, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other...
argenx Highlights 2025 Strategic Priorities
January 13, 2025 01:00 ET
|
argenx SE
Reported $2.2 billion in preliminary* full-year 2024 global product net sales, inclusive of $737 million in fourth quarter sales Pre-filled syringe FDA PDUFA on track for April 2025 to support...
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
January 13, 2025 00:05 ET
|
Lantheus Holdings, Inc.
Enhances Lantheus’ growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s Disease Advances Lantheus’...
Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities
January 12, 2025 21:00 ET
|
Praxis Precision Medicines, Inc.
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by 2028 Study 1 of Essential3 program for ulixacaltamide...
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
January 12, 2025 20:04 ET
|
Merus N.V.
NEW HAVEN, Conn. and UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Biohaven Ltd. (NYSE: BHVN) and Merus N.V. (Nasdaq:MRUS), today announced a research...
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
January 12, 2025 19:05 ET
|
Caribou Biosciences, Inc.
-- CB-010 GALLOP Phase 1 trial initiated in lupus -- -- CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L LBCL...